Biomarkers and clinical outcomes in COPD: A systematic review and meta-analysis

Jilles M. Fermont*, Katya L. Masconi, Magnus T. Jensen, Renata Ferrari, Valéria A.P. Di Lorenzo, Jacob M. Marott, Philipp Schuetz, Henrik Watz, Benjamin Waschki, Hana Müllerova, Michael I. Polkey, Ian B. Wilkinson, Angela M. Wood

*Corresponding author af dette arbejde
    78 Citationer (Scopus)

    Abstract

    Background Conventional measures to evaluate COPD may fail to capture systemic problems, particularly musculoskeletal weakness and cardiovascular disease. Identifying these manifestations and assessing their association with clinical outcomes (ie, mortality, exacerbation and COPD hospital admission) is of increasing clinical importance. Objective To assess associations between 6 min walk distance (6MWD), heart rate, fibrinogen, C reactive protein (CRP), white cell count (WCC), interleukins 6 and 8 (IL-6 and IL-8), tumour necrosis factor-alpha, quadriceps maximum voluntary contraction, sniff nasal inspiratory pressure, short physical performance battery, pulse wave velocity, carotid intima-media thickness and augmentation index and clinical outcomes in patients with stable COPD. Methods We systematically searched electronic databases (August 2018) and identified 61 studies, which were synthesised, including meta-analyses to estimate pooled HRs, following Meta-analysis of Observational Studies in Epidemiology (MOOSE) and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Results Shorter 6MWD and elevated heart rate, fibrinogen, CRP and WCC were associated with higher risk of mortality. Pooled HRs were 0.80 (95% CI 0.73 to 0.89) per 50 m longer 6MWD, 1.10 (95% CI 1.02 to 1.18) per 10 bpm higher heart rate, 3.13 (95% CI 2.14 to 4.57) per twofold increase in fibrinogen, 1.17 (95% CI 1.06 to 1.28) per twofold increase in CRP and 2.07 (95% CI 1.29 to 3.31) per twofold increase in WCC. Shorter 6MWD and elevated fibrinogen and CRP were associated with exacerbation, and shorter 6MWD, higher heart rate, CRP and IL-6 were associated with hospitalisation. Few studies examined associations with musculoskeletal measures. Conclusion Findings suggest 6MWD, heart rate, CRP, fibrinogen and WCC are associated with clinical outcomes in patients with stable COPD. Use of musculoskeletal measures to assess outcomes in patients with COPD requires further investigation. Trial registration number CRD42016052075.

    OriginalsprogEngelsk
    TidsskriftThorax
    Vol/bind74
    Udgave nummer5
    Sider (fra-til)439-446
    Antal sider8
    ISSN0040-6376
    DOI
    StatusUdgivet - 1 maj 2019

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Biomarkers and clinical outcomes in COPD: A systematic review and meta-analysis'. Sammen danner de et unikt fingeraftryk.

    Citationsformater